Sinopharm, China largest drug and medical device distributor, obtained exclusive China rights to a wound healing technology developed by Avita Medical of Australia. RES™ (Regenerative Epithelial Suspension) combines a small sample of a patient’s skin with multi-phenotype skin cells that promote healing. RES™, which is available in 30 minutes, is used for burn and chronic wounds. The technology is CFDA approved for use in China.
